Association between alopecia areata and COVID-19: A systematic review
- PMID: 35165668
- PMCID: PMC8828419
- DOI: 10.1016/j.jdin.2022.02.002
Association between alopecia areata and COVID-19: A systematic review
Abstract
Background: COVID-19 may play a role in various immune-related dermatologic conditions. The relationship between COVID-19 and alopecia areata remains unclear.
Objective: To review the existing literature for clinical studies and reports investigating the association between new-onset alopecia areata or the exacerbation of preexisting alopecia areata following infection with SARS-CoV-2.
Methods: A systematic review of the literature was performed using PubMed, Embase, and MEDLINE databases from inception to October 2021. Included articles assessed alopecia areata following infection with SARS-CoV-2.
Results: Of 402 total articles, 9 were identified as meeting the inclusion criteria. Six articles described case reports of 7 patients with new-onset alopecia areata following confirmed infection with SARS-CoV-2, and 3 articles reported on alopecia areata recurrence or exacerbation following SARS-CoV-2 infection in patients with preexisting disease. Studies investigating the exacerbation or recurrence of alopecia areata following infection reported mixed findings.
Limitations: A majority of the included studies were case reports. The heterogeneity of articles precluded data synthesis.
Conclusion: Alopecia areata may be a dermatologic manifestation of COVID-19, with cases most often appearing 1 to 2 months following infection. Additional research is necessary to better elucidate the relationship and draw conclusions.
Keywords: AA; COVID-19; SARS-CoV-2; alopecia areata; inflammation.
© 2022 by the American Academy of Dermatology, Inc. Published by Elsevier Inc.
Conflict of interest statement
None disclosed.
Figures
References
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous